Drug intelligence / Profile preview

Icy Hot Micro Patch

Development stage: Phase 4
Lead developer: Chattem
Modality: Small Molecules
Administration: Transdermal

Overview

Icy Hot Micro Patch is an approved over-the-counter transdermal analgesic patch containing **menthol** as its active ingredient. The product is manufactured by Lead Chemical Co. and distributed in the United States by Chattem. It is indicated for the temporary relief of pain and is designed for localized skin application to deliver menthol through a patch matrix. Pharmacologically, menthol acts as a topical counterirritant that produces a cooling sensation and modulates sensory nerve signaling to reduce the perception of minor pain in the treated area.

Brand names: Icy Hot Micro Patch
Other names: Icy Hot Medicated MicroIcy Hot Micro

Targets

TRPM8 (Transient receptor potential cation channel subfamily M member 8)

Beyond the preview

Go deeper on Icy Hot Micro Patch.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Icy Hot Micro Patch.

Explore the full profile